In agreement with these findings, a number of studies report elevated levels of CCL2 in the serum of cancer patients and/or an association between elevated serum CCL2 and poor prognosis: Moogooei et al. [47] and Pan et al. [48] report elevated levels of serum CCL2 in patients with glial tumors and lung cancer. Here, CCL2 is linked to cancer.